285 related articles for article (PubMed ID: 37190048)
41. Identification of an immune overdrive high-risk subpopulation with aberrant expression of FOXP3 and CTLA4 in colorectal cancer.
Cui K; Yao S; Zhang H; Zhou M; Liu B; Cao Y; Fei B; Huang S; Huang Z
Oncogene; 2021 Mar; 40(11):2130-2145. PubMed ID: 33627780
[TBL] [Abstract][Full Text] [Related]
42. Epithelial Smad4 Deletion Up-Regulates Inflammation and Promotes Inflammation-Associated Cancer.
Means AL; Freeman TJ; Zhu J; Woodbury LG; Marincola-Smith P; Wu C; Meyer AR; Weaver CJ; Padmanabhan C; An H; Zi J; Wessinger BC; Chaturvedi R; Brown TD; Deane NG; Coffey RJ; Wilson KT; Smith JJ; Sawyers CL; Goldenring JR; Novitskiy SV; Washington MK; Shi C; Beauchamp RD
Cell Mol Gastroenterol Hepatol; 2018; 6(3):257-276. PubMed ID: 30109253
[TBL] [Abstract][Full Text] [Related]
43. Spatial transcriptomics atlas reveals the crosstalk between cancer-associated fibroblasts and tumor microenvironment components in colorectal cancer.
Peng Z; Ye M; Ding H; Feng Z; Hu K
J Transl Med; 2022 Jul; 20(1):302. PubMed ID: 35794563
[TBL] [Abstract][Full Text] [Related]
44. Loss of SMAD4 alters BMP signaling to promote colorectal cancer cell metastasis via activation of Rho and ROCK.
Voorneveld PW; Kodach LL; Jacobs RJ; Liv N; Zonnevylle AC; Hoogenboom JP; Biemond I; Verspaget HW; Hommes DW; de Rooij K; van Noesel CJ; Morreau H; van Wezel T; Offerhaus GJ; van den Brink GR; Peppelenbosch MP; Ten Dijke P; Hardwick JC
Gastroenterology; 2014 Jul; 147(1):196-208.e13. PubMed ID: 24704720
[TBL] [Abstract][Full Text] [Related]
45. Estrogen receptor α or β loss in the colon of Min/+ mice promotes crypt expansion and impairs TGFβ and HNF3β signaling.
Hasson RM; Briggs A; Carothers AM; Davids JS; Wang J; Javid SH; Cho NL; Bertagnolli MM
Carcinogenesis; 2014 Jan; 35(1):96-102. PubMed ID: 24104551
[TBL] [Abstract][Full Text] [Related]
46. Dual inhibition of TGFβ and AXL as a novel therapy for human colorectal adenocarcinoma with mesenchymal phenotype.
Ciardiello D; Blauensteiner B; Matrone N; Belli V; Mohr T; Vitiello PP; Martini G; Poliero L; Cardone C; Napolitano S; De Falco V; Giunta EF; Ciaramella V; Corte CD; Barra G; Selvaggi F; Franco R; Marino FZ; Cuomo A; Morgillo F; Troiani T; Sibilia M; Ciardiello F; Martinelli E
Med Oncol; 2021 Feb; 38(3):24. PubMed ID: 33570712
[TBL] [Abstract][Full Text] [Related]
47. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
Nenkov M; Ma Y; Gaßler N; Chen Y
Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
[TBL] [Abstract][Full Text] [Related]
48. Interplay between Signaling Pathways and Tumor Microenvironment Components: A Paradoxical Role in Colorectal Cancer.
Ben Hamouda S; Essafi-Benkhadir K
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982677
[TBL] [Abstract][Full Text] [Related]
49. The Role of Tumor-Associated Neutrophils in Colorectal Cancer.
Mizuno R; Kawada K; Itatani Y; Ogawa R; Kiyasu Y; Sakai Y
Int J Mol Sci; 2019 Jan; 20(3):. PubMed ID: 30691207
[TBL] [Abstract][Full Text] [Related]
50. TGFβ signaling directs serrated adenomas to the mesenchymal colorectal cancer subtype.
Fessler E; Drost J; van Hooff SR; Linnekamp JF; Wang X; Jansen M; De Sousa E Melo F; Prasetyanti PR; IJspeert JE; Franitza M; Nürnberg P; van Noesel CJ; Dekker E; Vermeulen L; Clevers H; Medema JP
EMBO Mol Med; 2016 Jul; 8(7):745-60. PubMed ID: 27221051
[TBL] [Abstract][Full Text] [Related]
51. Transgelin is a poor prognostic factor associated with advanced colorectal cancer (CRC) stage promoting tumor growth and migration in a TGFβ-dependent manner.
Elsafadi M; Manikandan M; Almalki S; Mahmood A; Shinwari T; Vishnubalaji R; Mobarak M; Alfayez M; Aldahmash A; Kassem M; Alajez NM
Cell Death Dis; 2020 May; 11(5):341. PubMed ID: 32393769
[TBL] [Abstract][Full Text] [Related]
52. Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation.
Dijkstra JJ; Neikes HK; Rezaeifard S; Ma X; Voest EE; Tauriello DVF; Vermeulen M
J Proteome Res; 2023 Jan; 22(1):138-151. PubMed ID: 36450103
[TBL] [Abstract][Full Text] [Related]
53. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway.
Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J
Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846
[TBL] [Abstract][Full Text] [Related]
54. Cancer-associated fibroblasts potentiate colorectal cancer progression by crosstalk of the IGF2-IGF1R and Hippo-YAP1 signaling pathways.
Zhang J; Chen B; Li H; Wang Y; Liu X; Wong KY; Chan WN; Chan AK; Cheung AH; Leung KT; Dong Y; Pan Y; Ke H; Liang L; Zhou Z; Xiao J; Wong CC; Wu WK; Cheng AS; Ma BB; Yu J; Lo KW; Kang W;
J Pathol; 2023 Feb; 259(2):205-219. PubMed ID: 36373776
[TBL] [Abstract][Full Text] [Related]
55. Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer.
Bierie B; Moses HL
Nat Rev Cancer; 2006 Jul; 6(7):506-20. PubMed ID: 16794634
[TBL] [Abstract][Full Text] [Related]
56. Transforming growth factor-β signaling: Tumorigenesis and targeting for cancer therapy.
Ahmadi A; Najafi M; Farhood B; Mortezaee K
J Cell Physiol; 2019 Aug; 234(8):12173-12187. PubMed ID: 30537043
[TBL] [Abstract][Full Text] [Related]
57. TGFβ: A player on multiple fronts in the tumor microenvironment.
Caja F; Vannucci L
J Immunotoxicol; 2015; 12(3):300-7. PubMed ID: 25140864
[TBL] [Abstract][Full Text] [Related]
58. Vemurafenib downmodulates aggressiveness mediators of colorectal cancer (CRC): Low Molecular Weight Protein Tyrosine Phosphatase (LMWPTP), Protein Tyrosine Phosphatase 1B (PTP1B) and Transforming Growth Factor β (TGFβ).
Cordeiro HG; de Sousa Faria AV; Ferreira-Halder CV
Biol Chem; 2020 Aug; 401(9):1063-1069. PubMed ID: 32229687
[TBL] [Abstract][Full Text] [Related]
59. Role of TGFβ in regulation of the tumor microenvironment and drug delivery (review).
Papageorgis P; Stylianopoulos T
Int J Oncol; 2015 Mar; 46(3):933-43. PubMed ID: 25573346
[TBL] [Abstract][Full Text] [Related]
60. Targeting the TGFβ pathway for cancer therapy.
Neuzillet C; Tijeras-Raballand A; Cohen R; Cros J; Faivre S; Raymond E; de Gramont A
Pharmacol Ther; 2015 Mar; 147():22-31. PubMed ID: 25444759
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
